Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Rosenberg

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2003
Adenovirus expressing p53Matthew Holmes, Elizabeth Rosenberg, Kristoffer Valerie
Anticancer Research|May 23, 2002
Sensitivity of nucleotide excision repair-deficient human cells to ionizing radiation and cyclophosphamideD Murray, Loretta Vallee-Lucic, Elizabeth Rosenberg, et al.
Current Osteoporosis Reports|January 10, 2012
Inhibition of cathepsin K for treatment of osteoporosisSteven Boonen, Elizabeth Rosenberg, Frank Claessens, et al.
Calcified Tissue International|February 26, 2013
In vitro and in vivo responses to high and low doses of nitrogen-containing bisphosphonates suggest engagement of different mechanisms for inhibition of osteoclastic bone resorptionJohn E Fisher, Elizabeth Rosenberg, Arthur C Santora, et al.
Biochimica Et Biophysica Acta|May 22, 2002
A role for C/EBP delta in human surfactant protein A (SP-A) gene expressionAnjaneyulu Matlapudi, Mengshu Wang, Elizabeth Rosenberg, et al.
Journal of Cosmetic Dermatology|March 18, 2021
Evaluation of alternative diluents for clinical use of collagenase clostridium histolyticum (CCH-aaes)Henry R Wolfe, Elizabeth Rosenberg, Kadriye Ciftci, et al.
European Journal of Clinical Investigation|September 25, 2012
The osteoclast, bone remodelling and treatment of metabolic bone diseaseBrendan F Boyce, Elizabeth Rosenberg, Anne E de Papp, et al.
The Journal of Urology|July 20, 2010
A multicenter, double-blind, randomized, placebo controlled trial of a neurokinin-1 receptor antagonist for overactive bladderTara L Frenkl, Haiyuan Zhu, Theodore Reiss, et al.
Current Medical Research and Opinion|June 28, 2007
Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral densitySydney Bonnick, Susan Broy, Fran Kaiser, et al.
Cancer Research|February 7, 2007
Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage responseSarah E Golding, Elizabeth Rosenberg, Steven Neill, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2003
Adenovirus expressing p53Matthew Holmes, Elizabeth Rosenberg, Kristoffer Valerie
Anticancer Research|May 23, 2002
Sensitivity of nucleotide excision repair-deficient human cells to ionizing radiation and cyclophosphamideD Murray, Loretta Vallee-Lucic, Elizabeth Rosenberg, et al.
Current Osteoporosis Reports|January 10, 2012
Inhibition of cathepsin K for treatment of osteoporosisSteven Boonen, Elizabeth Rosenberg, Frank Claessens, et al.
Calcified Tissue International|February 26, 2013
In vitro and in vivo responses to high and low doses of nitrogen-containing bisphosphonates suggest engagement of different mechanisms for inhibition of osteoclastic bone resorptionJohn E Fisher, Elizabeth Rosenberg, Arthur C Santora, et al.
Biochimica Et Biophysica Acta|May 22, 2002
A role for C/EBP delta in human surfactant protein A (SP-A) gene expressionAnjaneyulu Matlapudi, Mengshu Wang, Elizabeth Rosenberg, et al.
Journal of Cosmetic Dermatology|March 18, 2021
Evaluation of alternative diluents for clinical use of collagenase clostridium histolyticum (CCH-aaes)Henry R Wolfe, Elizabeth Rosenberg, Kadriye Ciftci, et al.
European Journal of Clinical Investigation|September 25, 2012
The osteoclast, bone remodelling and treatment of metabolic bone diseaseBrendan F Boyce, Elizabeth Rosenberg, Anne E de Papp, et al.
The Journal of Urology|July 20, 2010
A multicenter, double-blind, randomized, placebo controlled trial of a neurokinin-1 receptor antagonist for overactive bladderTara L Frenkl, Haiyuan Zhu, Theodore Reiss, et al.
Current Medical Research and Opinion|June 28, 2007
Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral densitySydney Bonnick, Susan Broy, Fran Kaiser, et al.
Cancer Research|February 7, 2007
Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage responseSarah E Golding, Elizabeth Rosenberg, Steven Neill, et al.
Pageof 5